{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibtonacdpxzyxtvrsnxui5jxzjcwsvq2aamzyajkygamhg6sffc5u",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlegziny4gy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiblucaq7oo5tscu6yu2no2ohjx7yljsi4ml5xmm3jt3aevnzqj5nu"
    },
    "mimeType": "image/jpeg",
    "size": 554830
  },
  "path": "/news/2026-05-urine-outperforms-mri-prostate-cancer.html",
  "publishedAt": "2026-05-08T13:40:09.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat \"monitoring\" biopsies would have avoided up to 64% of unnecessary biopsies while maintaining timely detection of higher-grade cancers that merit treatment, according to a study published in The Journal of Urology.",
  "title": "Urine test outperforms MRI for monitoring low-risk prostate cancer in new study"
}